Genzyme CVRs start trading; Incyte scores $15M milestone;

 @FierceBiotech: Westphal leaving SR One, concentrating on VC firm. News | Follow @FierceBiotech 

 @JohnCFierce: Inspire Pharma hit a wall in January when its CF drug flunked a Ph3. Merck is picking up the opthalmology pieces in the debris. | Follow @JohnCFierce

> Those CVRs Sanofi offered to complete the Genzyme acquisition started trading at $2.30. Story

> Incyte scored a $15 million milestone payment from Novartis based on the ongoing Phase I dose-escalation trial for INCB28060 (also known as INC280) in patients with solid tumors. Incyte release

> The FDA has approved an extended release version of Viramune, Boehringer's HIV drug. Story

> Champions Oncology has completed the private placement of 12.5 million shares of its common stock at a price of $0.75 per share, proving $9.4 million in financing. Report

Pharma News

@FiercePharma: Analysts: Expect more hostile bids in pharma. Story | Follow @FiercePharma

> Merck nabs eye specialist Inspire for $430M. Report

> Drugmakers: Canada-EU trade deal won't cost billions. Article

> Bankers expect more Japanese-led M&A. News

> Early hep C drug pricing spooks experts. Story

> Bayer to combine East Coast ops in NJ. Report

> Data questions Avastin safety for eye use. Article

Research News

> Former football player now studies athletes' genes. News

> Gene-patent courtroom drama plays out in Washington. Article

> Alzheimer's researchers have five new genes to ponder. Report

> Israeli biotech Pluristem uses stem cells from placentas. Story

> Nanoparticles provide protection against nickel allergies. Item

> Coming soon: 3D adult stem cells, no glasses required. Report

Manufacturing News

> India marks its fifth $1B drugmaker. Story

> Roche, Catalent suffer warehouse fires. Item

> McNeil consent decree quarantine helps J&J's bottom line. Report

> Merck, Roche add voice to pick operations. Article

> PAT, QbD spur continuous processing. News

> DNA links Lilly, GSK warehouse thefts. Report

And Finally... Investigators at UT Southwestern Medical Center say they have discovered how to block a dangerous spike in blood pressure often seen in patients suffering from hypertension when they exercise. Report